ATC Group: B03XA05 Roxadustat

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B03XA05 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B03 Antianemic preparations
3 B03X Other antianemic preparations
4 B03XA Other antianemic preparations
5 B03XA05

Active ingredients in B03XA05

Active Ingredient

Roxadustat is a hypoxia-inducible factor, prolyl hydroxylase inhibitor (HIF-PHI). The activity of HIF-PH enzymes controls intracellular levels of HIF, a transcription factor that regulates the expression of genes involved in erythropoiesis. Activation of the HIF pathway is important in the adaptative response to hypoxia to increase red blood cell production.

Related product monographs

Document Type Information Source  
 EVRENZO Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicines in this ATC group

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.